Infusion-Related Phlebitis — Is the In-Line Filter the Solution?

Abstract

Intravenous devices are inserted in approximately half the 40 million patients hospitalized each year in the United States.¹ The great benefits of administration of fluids and medication by this direct route to the circulation are obvious. The hazards are less well appreciated, possibly because those resulting in major morbidity and even mortality, such as cellulitis, bacteremia, septic thrombophlebitis, and disseminated infection, are fortunately infrequent if the proper technique is used. Minor complications, such as infiltration and phlebitis, are frequently accepted as inevitable concomitants of intravenous therapy. Although these complications are painful for the patient and annoying to the busy house . . .